Ketamine Recruiting Phase 2 Trials for Posttraumatic Stress Disorders Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02727998Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy